News & Blog

Dr. Loralyn Mears is the Director of Scientific Communications for Global Cancer Technology, and..

Global Cancer Technology Inc CEO John Clark tells Proactive the privately-held biopharmaceutical…

Together with scientists from the University of California San Diego, Global Cancer Technology (GCT)…

Global Cancer Technology Signs Agreement with Barrow Neurological Institute to…

Global Cancer Technology is Developing a Light-emitting Nanoparticle Which May…

GLOBAL CANCER TECHNOLOGY LICENSES AUTOPHAGY MODULATORS FROM NEUROPORE THERAPIES FOR

Company Plans to Raise $9 Million USD with Proceeds to Fund New COVID Treatment Using Nanoparticles, UV Light and…

Global Cancer Technology launches Regulation CF equity crowdfunding campaign.

Global Cancer Technology appoints UC San Diego Moores Cancer Center researcher, Dr…

New paradigm for killing deep-seated tumors without harming normal tissue.

22/22